Survival outcomes seen with neoadjuvant chemotherapy in the management of locally advanced inflammatory breast cancer (IBC) versus matched controls

Inflammatory breast cancer (IBC) poses an ongoing challenge as rates of disease recurrence and mortality remain high compared to stage-matched controls. However, frontline therapy has evolved through the years, including the widespread use of neoadjuvant chemotherapy (NAC) given the prognostic impor...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Kai CC, Grimm, Michael, Sukumar, Jasmine, Schnell, Patrick M., Park, Ko Un, Stover, Daniel G., Jhawar, Sachin R., Gatti-Mays, Margaret, Wesolowski, Robert, Williams, Nicole, Sardesai, Sagar, Pariser, Ashley, Sudheendra, Preeti, Tozbikian, Gary, Ramaswamy, Bhuvaneswari, Doto, Dureti, Cherian, Mathew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598404/
https://www.ncbi.nlm.nih.gov/pubmed/37871527
http://dx.doi.org/10.1016/j.breast.2023.103591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598404/
https://www.ncbi.nlm.nih.gov/pubmed/37871527
http://dx.doi.org/10.1016/j.breast.2023.103591

Ejemplares similares